Cargando…
Prospective investigation of drug resistance: an approach to understanding and optimizing the clinical benefit of targeted agents in Ewing sarcoma
Autor principal: | Bailey, Kelly M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6324671/ https://www.ncbi.nlm.nih.gov/pubmed/30647860 http://dx.doi.org/10.18632/oncotarget.26465 |
Ejemplares similares
-
Emerging novel agents for patients with advanced Ewing sarcoma: a report from the Children’s Oncology Group (COG) New Agents for Ewing Sarcoma Task Force
por: Bailey, Kelly, et al.
Publicado: (2019) -
Harnessing immunomodulation during DNA damage in Ewing sarcoma
por: Daley, Jessica D., et al.
Publicado: (2022) -
Potential approaches to the treatment of Ewing's sarcoma
por: Yu, Hongjiu, et al.
Publicado: (2016) -
Efficacy of ATR inhibitors as single agents in Ewing sarcoma
por: Nieto-Soler, Maria, et al.
Publicado: (2016) -
Soft Tissue Ewing Sarcoma Cell Drug Resistance Revisited: A Systems Biology Approach
por: Asfa, Seyedehsadaf, et al.
Publicado: (2023)